People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.64USD
11 Jul 2014
Price Change (% chg)

$0.61 (+8.68%)
Prev Close
$7.03
Open
$6.98
Day's High
$7.96
Day's Low
$6.97
Volume
7,832,120
Avg. Vol
6,239,139
52-wk High
$8.61
52-wk Low
$2.26

Search Stocks

Shah, Gautam 

Brief Biography

Dr. Gautam Shah, Ph.D., is Executive Vice President, Chief Compliance Officer of Achillion Pharmaceuticals, Inc. Prior to joining Achillion in May 2004, Dr. Shah was Senior Director of Regulatory Affairs with Sepracor, a pharmaceutical company, from February 2003 to May 2004. Prior to Sepracor, Dr. Shah was in the Regulatory Affairs Group of Bayer Health Care, a pharmaceutical company. Before Bayer, he held positions of increasing responsibilities at Pfizer Inc., a pharmaceutical company, in the area of Product and Process Development. Dr. Shah received his Ph.D. in Pharmaceutics from the University of Illinois, as well as a M.S. in Medicinal Chemistry from Wayne State University and a B.A. in Pharmacy from MSU University in India.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
410,476 -- 472,767 883,243

Options Compensation

  Quantity Market Value
Exercisable 300,000 --
Unexercisable -- --
Exercised 26,965 141,792.00
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

4,853,430

Mary Kay Fenton

989,616

Gautam Shah

883,243

David Apelian

2,175,130

Joseph Truitt

886,617
As Of 30 Dec 2013
Search Stocks